Status:
COMPLETED
Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Conditions:
Post-COVID19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
With the progression of the SARS-CoV-2 pandemic there's an increasing number of patients recovering from COVID19. Some of these patients still experience hypoxemia and therefore are still in need of a...
Detailed Description
Rationale After an infection with SARS-CoV-2, some patients still experience hypoxemia even after being discharged from the hospital. Long-term oxygen therapy (LTOT) is then used to increase the pati...
Eligibility Criteria
Inclusion
- validated COVID19 disease in case history
- hypoxemia (PO2 \< 55 mmHg) under room air conditions (rest or during exercise) or SpO2 \<88% during exercise
- already established Long-term oxygen therapy or given indication for a Long-term oxygen therapy
Exclusion
- acute infection
- cardiovascular diseases that limit physical fitness
- orthopedic diseases preventing the patient from undergoing the walking tests
Key Trial Info
Start Date :
April 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04849598
Start Date
April 13 2021
End Date
August 27 2021
Last Update
November 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Berchtesgadener Land, Schön Kliniken
Schönau am Königssee, Bavaria, Germany, 83471